The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Sulfonimidamides in Medicinal and Agricultural Chemistry
Abstract
The synthesis and evaluation of structural analogues and isosteres are of central importance in medicinal and agricultural chemistry. The sulfonamide functional group represents one of the most important amide isosteres in contemporary drug design, and about 500 such compounds have overcome both the pharmacological and regulatory hurdles that precede studies in humans. The mono aza analogues of sulfonamides, that is, sulfonimidamides, are rapidly gaining popularity as a novel functional group among synthetic chemists involved in the design of biologically active compounds for both pharmaceutical and agrochemical applications. Herein, we review these recent developments to showcase the promise of this functional group.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Shoman, M. E., & Aly, O. M. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/4867124 · Cited by 14
RetractedSynopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
Meanwell, N. A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1013693 · Cited by 2,854
The influence of drug-like concepts on decision-making in medicinal chemistry
Leeson, P. D., & Springthorpe, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2445 · Cited by 2,403
The role of ligand efficiency metrics in drug discovery
Hopkins, A. L., Keserü, G. M., Leeson, P. D., Rees, D. C., & Reynolds, C. H. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4163 · Cited by 1,181
Sulfoximines: A Neglected Opportunity in Medicinal Chemistry
Lücking, U. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201302209 · Cited by 672
Carbonic anhydrase inhibitors and their therapeutic potential
Supuran, C. T., & Scozzafava, A. (2000) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.10.5.575 · Cited by 549
Carboxylic Acid (Bio)Isosteres in Drug Design
Ballatore, C., Huryn, D. M., & Smith, A. B. (2013) · ChemMedChem · doi:10.1002/cmdc.201200585 · Cited by 523
Frings, M., Bolm, C., Blum, A., & Gnamm, C. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.09.091 · Cited by 501
Sparks, T. C., Watson, G. B., Loso, M. R., Geng, C., Babcock, J. M., & Thomas, J. D. (2013) · Pesticide Biochemistry and Physiology · doi:10.1016/j.pestbp.2013.05.014 · Cited by 365
Nitroxyl (HNO): the Cinderella of the nitric oxide story
Irvine, J. C., Ritchie, R. H., Favaloro, J. L., Andrews, K. L., Widdop, R. E., & Kemp-Harper, B. K. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.08.005 · Cited by 277
Acyl glucuronides: the good, the bad and the ugly
Regan, S. L., Maggs, J. L., Hammond, T. G., Lambert, C., Williams, D. P., & Park, B. K. (2010) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.720 · Cited by 185
Shoaib Ahmad Shah, S., Rivera, G., & Ashfaq, M. (2013) · Mini Reviews in Medicinal Chemistry · doi:10.2174/138955713804484749 · Cited by 184
NITROXYL (HNO): Chemistry, Biochemistry, and Pharmacology
Fukuto, J. M., Switzer, C., Miranda, K. M., & Wink, D. A. (2005) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095959 · Cited by 133
Sulfoximine: Eine vernachlässigte Chance in der medizinischen Chemie
Lücking, U. (2013) · Angewandte Chemie · doi:10.1002/ange.201302209 · Cited by 131
Sehgelmeble, F. W., Janson, J., Ray, C., Rosqvist, S., Gustavsson, S., Nilsson, L. I., Minidis, A. B. E., Holenz, J., Rotticci, D., Lundkvist, J., et al. (2012) · ChemMedChem · doi:10.1002/cmdc.201200014 · Cited by 103
Self-citation8-epi-Salvinorin B: crystal structure and affinity at the κ opioid receptor
Munro, T. A., Duncan, K. K., Staples, R. J., Xu, W., Liu‐Chen, L., Béguin, C., Carlezon, W. A., & Cohen, B. M. (2007) · Beilstein Journal of Organic Chemistry · doi:10.1186/1860-5397-3-1 · Cited by 91
Natural Product Primary Sulfonamides and Primary Sulfamates
Mujumdar, P., & Poulsen, S. (2015) · Journal of Natural Products · doi:10.1021/np501015m · Cited by 80
Borhade, S. R., Svensson, R., Brandt, P., Artursson, P., Arvidsson, P. I., & Sandström, A. (2015) · ChemMedChem · doi:10.1002/cmdc.201402497 · Cited by 73
Self-citationSteinkamp, A., Schmitt, L., Chen, X., Fietkau, K., Heise, R., Baron, J. M., & Bolm, C. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000453042 · Cited by 38
Sjö, P. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.17 · Cited by 32
N-Hydroxy sulfonimidamides as new nitroxyl (HNO) donors
Pennington, R. L., Sha, X., & King, S. B. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.02.082 · Cited by 19
Cited by
Mäder, P., & Kattner, L. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00960 · Cited by 438
Lücking, U. (2019) · Organic Chemistry Frontiers · doi:10.1039/c8qo01233d · Cited by 364
Sulfonamide derivatives as multi-target agents for complex diseases
Apaydın, S., & Török, M. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.06.041 · Cited by 256
Metadata
- Authors
- Chinthakindi, P. K., Naicker, T., Thota, N., Govender, T., Kruger, H. G., & Arvidsson, P. I.
- Venue
- Angewandte Chemie International Edition
- Publisher
- Wiley
- Published
- 2017-02-23
- Volume
- 56
- Issue
- 15
- Pages
- 4100-4109
- ISSN
- 1433-7851 (ISSN-L)
- 1521-3773
- OpenAlex
- W2590729009
- Cited by
- 271
- References
- 21
- FWCI
- 6.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.